Sort
23,748 grants matching “melanoma”
Controlled Release of Macromolecules
$399,667Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2012 · EB
Large-Scale Characterization of Anti-Cancer Antibody Responses in Lung Adenocarci
$399,643William H Robinson · Stanford University · R33 · FY2014 · CA
Large-Scale Characterization of Anti-Cancer Antibody Responses in Lung Adenocarci
$399,643William H Robinson · Stanford University · R33 · FY2016 · CA
Large-Scale Characterization of Anti-Cancer Antibody Responses in Lung Adenocarci
$399,643William H Robinson · Stanford University · R33 · FY2015 · CA
Integrative Cancer Genomics: Drivers, Pathways and Drugs
$399,632Dana Pe'er · Columbia Univ New York Morningside · R01 · FY2012 · CA
PLA2G2D Antibodies for Cancer Immunotherapy
$399,618Li-Fen Lee · Apeximmune Therapeutics Inc. · R43 · FY2023 · CA
Project 2
$399,609Ryan Bruce Corcoran · Massachusetts General Hospital · U54 · FY2020 · CA
TARGETING EPIGENETIC REGULATOR JARIDIB IN MALIGNANT MELANOMA
$399,600Yale Univ · · FY2013 · Department of Defense
Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer
$399,586Fatemeh Sadat Majedi · Symphony Biosciences, Inc. · R44 · FY2023 · CA
ERK control of Dendritic Cell Differentiation, Homeostasis and Disease
$399,583Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA
Platelet Serine/Threonine Phosphatases in Cancer Pathophysiology
$399,554K. Vinod Vijayan · Baylor College Of Medicine · R01 · FY2024 · CA
Development of Programmable mRNA Circuits for Melanoma Immunotherapy
$399,508Ryan Sowell · Strand Therapeutics Inc · R43 · FY2021 · CA
An innovative telomerase-targeted, circulating tumor cell assay for monitoring NSCLC treated with radiation and immunotherapy
$399,499Deeksha Saxena · Liquid Biodx Llc · R43 · FY2023 · CA
SOUTHWEST ONCOLOGY GROUP
$399,443Swedish Medical Center, First Hill · U10 · FY2002 · CA
The role of the CD58:CD2 axis in cancer immune evasion and resistance to immunotherapy
$399,379Benjamin Izar · Columbia University Health Sciences · R01 · FY2023 · CA
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma
$399,338Daniela Annenelie Bota · University Of California-Irvine · R01 · FY2024 · NS
Understanding PPARgamma signaling in melanoma brain metastasis
$399,305Qing Chen · Wistar Institute · R01 · FY2023 · CA
Targeted Delivery of Tumor Antigen esaRNA to the Spleen for Cancer Immunotherapy
$399,300Jasdave Chahal · Tiba Biotech, Llc · R43 · FY2025 · CA
Augmenting focused ultrasound-mediated drug delivery to brain tumors with vascular normalization
$399,294Richard J Price · University Of Virginia · R21 · FY2024 · CA
Activation and Regulation of the Understudied Kinome Using MIB/MS Technology
$399,282Gary L. Johnson · Univ Of North Carolina Chapel Hill · U01 · FY2014 · MH
Role of Desmoglein 1 in Keratinocyte-Melanocyte Communication and Melanoma
$399,195Kathleen Janee Green · Northwestern University At Chicago · R01 · FY2021 · CA
Statistical Methods for Population Genomics and "Next-gen" Sequencing Data
$399,128Paul A Scheet · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · HG
A redox-mediated mechanism of UVB-induced metabolic switch in skin carcinogenesis
$399,091Daret K St Clair · University Of Kentucky · R01 · FY2019 · CA
Antigen-independent prediction and biomarker identification of cancer-specific T cells
$399,032Bo Li · Children'S Hosp Of Philadelphia · R01 · FY2023 · CA
The mutational mechanisms shaping melanocytes in human skin
$399,002Alan Hunter Shain · University Of California, San Francisco · R01 · FY2024 · AR